Foreign-Trade Zone 153-San Diego, CA; Application for Manufacturing Authority; Abbott Cardiovascular Systems, Inc. (Cardiovascular Device Manufacturing); Riverside County, CA, 4283 [2011-1506]

Download as PDF 4283 Federal Register / Vol. 76, No. 16 / Tuesday, January 25, 2011 / Notices LIST OF PETITIONS RECEIVED BY EDA FOR CERTIFICATION OF ELIGIBILITY TO APPLY FOR TRADE ADJUSTMENT ASSISTANCE 1/6/2011 THROUGH 1/19/2011—Continued Firm name Address Date accepted for investigation Products Hydra-Pro, Inc ........................................ 2260 W Commodore Way, Seattle, WA 98199. 5885 Highway 311, Houma, LA 70360 12–Jan–11 ............ The firm manufactures custom marine and offshore cranes. The firm processes fresh fish from basic cleaning to custom cuts and packaging. The firm develops, manufactures, and sells motion control products and services for factory automation. The firm provides rapid prototyping, prototype development, and manufacturing engineering consulting services. The firm custom manufactures various wear and corrosion resistant silicon carbide components for industrial customers. Jensen Tuna Inc ..................................... Ormec Systems Corp ............................. 19 Linden Park, 14625–2712. NY 12–Jan–11 ............ ProtoCAM ............................................... 3848 Cherryville Road, Northampton, PA 18067. 11–Jan–11 ............ Silicon Carbide Products, Inc ................. 361 Daniel Zenker Drive, Horseheads, NY 14845. 40553 .................... Any party having a substantial interest in these proceedings may request a public hearing on the matter. A written request for a hearing must be submitted to the Trade Adjustment Assistance for Firms Division, Room 7106, Economic Development Administration, U.S. Department of Commerce, Washington, DC 20230, no later than ten (10) calendar days following publication of this notice. Please follow the requirements set forth in EDA’s regulations at 13 CFR 315.9 for procedures to request a public hearing. The Catalog of Federal Domestic Assistance official number and title for the program under which these petitions are submitted is 11.313, Trade Adjustment Assistance for Firms. Dated: January 19, 2011. Miriam Kearse, Eligibility Certifier. [FR Doc. 2011–1450 Filed 1–24–11; 8:45 am] BILLING CODE 3510–24–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [Docket 6–2011] mstockstill on DSKH9S0YB1PROD with NOTICES Foreign-Trade Zone 153—San Diego, CA; Application for Manufacturing Authority; Abbott Cardiovascular Systems, Inc. (Cardiovascular Device Manufacturing); Riverside County, CA An application has been submitted to the Foreign-Trade Zones Board (the Board) by the City of San Diego, grantee of FTZ 153, requesting manufacturing authority on behalf of Abbott Cardiovascular Systems, Inc. (Abbott), located in Riverside County, California. The application was submitted pursuant to the provisions of the Foreign-Trade VerDate Mar<15>2010 18:40 Jan 24, 2011 Jkt 223001 Rochester, 06–Jan–11 ............ Zones Act, as amended (19 U.S.C. 81a– 81u), and the regulations of the Board (15 CFR part 400). It was formally filed on January 18, 2011. The Abbott facilities (3,500 employees, up to 9 million units per year) are located within three sites of FTZ 153: Site 11 (54.2 acres) is located at 26531 Ynez Road, Temecula; Site 12 (8.3 acres) is located at 42301 Zevo Drive, Temecula; and, Site 13 (4.4 acres) is located at 30590 Cochise Circle, Murrieta. The facilities are used for the production of cardiovascular devices including stents, catheters and guidewires. Components and materials sourced from abroad (representing 5% of the value of the finished product) include: resins, plastic tubing, stent components, plastic packaging, plastic clips, nickel tubing and tantalum tubing (duty rate ranges from 2 to 6.5%). The application also requests authority to include a broad range of inputs and finished cardiovascular devices that Abbott may produce under FTZ procedures in the future. New major activity involving these inputs/products would require review by the FTZ Board. FTZ procedures could exempt Abbott from customs duty payments on the foreign components used in export production. The company anticipates that some 50 percent of the plants’ shipments will be exported. On its domestic sales, Abbott would be able to choose the duty rate during customs entry procedures that applies to the finished cardiovascular devices (duty free) for the foreign inputs noted above. FTZ designation would further allow Abbott to realize logistical benefits through the use of weekly customs entry procedures. Customs duties also could possibly be deferred or reduced on foreign status production equipment. PO 00000 Frm 00006 Fmt 4703 Sfmt 9990 The request indicates that the savings from FTZ procedures would help improve the facilities’ international competitiveness. In accordance with the Board’s regulations, Diane Finver of the FTZ Staff is designated examiner to evaluate and analyze the facts and information presented in the application and case record and to report findings and recommendations to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is March 28, 2011. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to April 11, 2011. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via https:// www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: January 18, 2011. Andrew McGilvray, Executive Secretary. [FR Doc. 2011–1506 Filed 1–24–11; 8:45 am] BILLING CODE P E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 76, Number 16 (Tuesday, January 25, 2011)]
[Notices]
[Page 4283]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1506]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 6-2011]


Foreign-Trade Zone 153--San Diego, CA; Application for 
Manufacturing Authority; Abbott Cardiovascular Systems, Inc. 
(Cardiovascular Device Manufacturing); Riverside County, CA

    An application has been submitted to the Foreign-Trade Zones Board 
(the Board) by the City of San Diego, grantee of FTZ 153, requesting 
manufacturing authority on behalf of Abbott Cardiovascular Systems, 
Inc. (Abbott), located in Riverside County, California. The application 
was submitted pursuant to the provisions of the Foreign-Trade Zones 
Act, as amended (19 U.S.C. 81a-81u), and the regulations of the Board 
(15 CFR part 400). It was formally filed on January 18, 2011.
    The Abbott facilities (3,500 employees, up to 9 million units per 
year) are located within three sites of FTZ 153: Site 11 (54.2 acres) 
is located at 26531 Ynez Road, Temecula; Site 12 (8.3 acres) is located 
at 42301 Zevo Drive, Temecula; and, Site 13 (4.4 acres) is located at 
30590 Cochise Circle, Murrieta. The facilities are used for the 
production of cardiovascular devices including stents, catheters and 
guidewires. Components and materials sourced from abroad (representing 
5% of the value of the finished product) include: resins, plastic 
tubing, stent components, plastic packaging, plastic clips, nickel 
tubing and tantalum tubing (duty rate ranges from 2 to 6.5%). The 
application also requests authority to include a broad range of inputs 
and finished cardiovascular devices that Abbott may produce under FTZ 
procedures in the future. New major activity involving these inputs/
products would require review by the FTZ Board.
    FTZ procedures could exempt Abbott from customs duty payments on 
the foreign components used in export production. The company 
anticipates that some 50 percent of the plants' shipments will be 
exported. On its domestic sales, Abbott would be able to choose the 
duty rate during customs entry procedures that applies to the finished 
cardiovascular devices (duty free) for the foreign inputs noted above. 
FTZ designation would further allow Abbott to realize logistical 
benefits through the use of weekly customs entry procedures. Customs 
duties also could possibly be deferred or reduced on foreign status 
production equipment. The request indicates that the savings from FTZ 
procedures would help improve the facilities' international 
competitiveness.
    In accordance with the Board's regulations, Diane Finver of the FTZ 
Staff is designated examiner to evaluate and analyze the facts and 
information presented in the application and case record and to report 
findings and recommendations to the Board.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the address below. The closing period for their receipt is 
March 28, 2011. Rebuttal comments in response to material submitted 
during the foregoing period may be submitted during the subsequent 15-
day period to April 11, 2011.
    A copy of the application will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via https://www.trade.gov/ftz.
    For further information, contact Diane Finver at 
Diane.Finver@trade.gov or (202) 482-1367.

    Dated: January 18, 2011.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2011-1506 Filed 1-24-11; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.